Data Transforms Your
E-commerce Solution

FREE WEB CONFERENCE

October 8th

E-commerce ROI
in 30 Days
Thru Data & Search

On Demand
More Information: www.b2becommercesuccess.com
Paid Advertising Banner

Palatin to Report Third Quarter, Fiscal Year 2021 Results; Teleconference and Webcast to be held on May 17, 2021


CRANBURY, N.J., May 13, 2021 /PRNewswire/ — Palatin Technologies, Inc. (NYSE American: PTN) will announce its third quarter, fiscal year 2021 operating results on Monday, May 17, 2021 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on May 17, 2021 at 11:00 a.m. ET. The conference call will include a review of the company’s operating results and an update on programs under development.

Schedule for the Operating Results Press Release, Conference Call / Audio Webcast



Q3 Fiscal Year 2021 Results Press Release               

5/17/2021 at 7:30 a.m. ET



Q3 Fiscal Year 2021 Conference Call-Live                  

5/17/2021 at 11:00 a.m. ET

US/Canada Dial-In Number:                                          

1-866-248-8441

International Dial-In Number:                                          

1-856-344-9206

Conference ID:                                                                 

6765353



Q3 Fiscal Year 2021 Conference Call-Replay               

5/17/2021-5/24/2021

US/Canada Dial-In Number:                                           

1-888-203-1112

International Dial-In Number:                                           

1-719-457-0820

Replay Passcode:                                                             

6765353



Audio Webcast Live and Replay Access                             

http://www.palatin.com

The audio webcast and replay can be accessed by logging on to the “Investors-Webcasts” section of Palatin’s website at http://www.palatin.com.

About Palatin
Palatin is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com.

SOURCE Palatin Technologies, Inc.

Related Links

http://www.palatin.com



Source link